| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e1dfcbdcafbe3a4a72ef04553310205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_365df12689c72a3c0fd713fbd6a3c735 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2014-11-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a19358863552d4f9e252ea78246a8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23cf870b4368bda86f51106e15b3d183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a503fcfc912edf29739e5cc4845edc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22a618366bc08519fc77ca1698aa8ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2fad172e36555882846345bf3ecca0 |
| publicationDate |
2019-10-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3553519-A1 |
| titleOfInvention |
Olfactomedin-4, neudesin and desmoplakin as novel biomarkers of breast cancer |
| abstract |
The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis of breast cancer. The invention is more particularly based on the finding that specific biomarkers such as Neudesin, Olfactomedin-4 and Desmoplakin are aberrantly expressed in the blood serum of breast cancer patients. |
| priorityDate |
2013-11-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |